SCHEMBL10279136

SCHEMBL10279136

Ic1cn2ccsc2n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5041270 0.74
SCHEMBL2386792 0.74
SCHEMBL1590685 0.74
SCHEMBL436536 0.74
SCHEMBL4147815 0.72 NPC1 (0.66)
SCHEMBL9570044 0.71 ALDH1A1 (0.53)
SCHEMBL12631459 0.70 SMN1; SMN2 (0.52)
SCHEMBL4764484 0.69 NPC1 (0.56)
SCHEMBL12338477 0.69 ALDH1A1 (0.53)
SCHEMBL14536391 0.69 SMN1; SMN2 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2468752-A1 Thiazolopyridine derivatives as sirtuin-modulators Sirtris Pharmaceuticals, Inc. (US) 2012-06-27 EP disclosed
EP-2388263-A1 Imidazo[2,1-b]thiazole derivatives as sirtuin modulators Sirtris Pharmaceuticals, Inc. (US) 2011-11-23 EP disclosed
WO-2010011331-A2 COMPOSITIONS AND METHODS RELATED TO SIRT1 FUNCTION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2010-01-28 WO disclosed
WO-2009053378-A1 PROCESS FOR THE PREPARATION OF 6-SUBSTITUTED-IMIDAZO [2,1-B] THIAZOLE-5-SULFONYL HALIDE LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2009-04-30 WO disclosed
WO-2007008895-A1 KINASE INHIBITORS ALLERGAN, INC. (US) 2007-01-18 WO disclosed